Rua Bioscience Limited (NZE:RUA)
New Zealand
· Delayed Price · Currency is NZD 0.0290
0.00 (0.00%)
Feb 28, 2025, 4:59 PM NZST
Rua Bioscience Revenue
Rua Bioscience had revenue of 174.94K NZD in the half year ending June 30, 2024, a decrease of -38.54%. This brings the company's revenue in the last twelve months to 1.06M, up 87.16% year-over-year. In the fiscal year ending June 30, 2024, Rua Bioscience had annual revenue of 316.35K, down -52.68%.
Revenue (ttm)
1.06M
Revenue Growth
+87.16%
P/S Ratio
4.10
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.91M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fisher & Paykel Healthcare Corporation | 1.89B |
| EBOS Group | 13.92B |
| Summerset Group Holdings | 319.90M |
| Ryman Healthcare | 720.35M |
| Arvida Group | 241.93M |
| Oceania Healthcare | 266.69M |
| AFT Pharmaceuticals | 198.51M |
| Green Cross Health | 513.61M |